Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retroperitoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05345158
What this trial is testing

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Who this might be right for
Lymphadenopathy RetroperitonealStage II Testicular Seminoma
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Study completedNCT00416455
What this trial is testing

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more
National Cancer Institute (NCI) 384
Post-approval studies (Phase 4)Active Not RecruitingNCT04033081
What this trial is testing

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Who this might be right for
Sarcoma
CivaTech Oncology 100
Early research (Phase 1)Study completedNCT04619056
What this trial is testing

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Soft Tissue SarcomaRecurrent Soft Tissue Sarcoma
CEBIOTEX 21
Not applicableActive Not RecruitingNCT02537548
What this trial is testing

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

Who this might be right for
LymphadenopathyStage I Testicular SeminomaStage II Testicular Seminoma
University of Southern California 55
Not applicableLooking for participantsNCT07432932
What this trial is testing

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Who this might be right for
SarcomaSarcoma, Leiomyo-, AdultSarcoma, Synovial, Adult+9 more
Royal Marsden NHS Foundation Trust 800
Not applicableUnknownNCT06565598
What this trial is testing

Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy

Who this might be right for
Nonfunctional KidneyRenal Cancer
The First People's Hospital of Xiushui 150
Testing effectiveness (Phase 2)Looking for participantsNCT07007182
What this trial is testing

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaStomach Neoplasms
Jinbo Yue 54
Not applicableStudy completedNCT06543095
What this trial is testing

Rib Removal and Pain in Partial Nephrectomy

Who this might be right for
PainPartial NephrectomyKidney Cancer
TC Erciyes University 50
Not applicableStudy completedNCT05044624
What this trial is testing

Retroperıtoneal Soft-Tıssue Sarcomas

Who this might be right for
Retroperitoneal SarcomaMargin, Tumor-Free
Istanbul Medeniyet University 18
Not applicableEnded earlyNCT03283423
What this trial is testing

Image-guided Lymphadanectomy in AMIGO

Who this might be right for
Lymphadenopathy RetroperitonealLymphoma
Brigham and Women's Hospital 11
Not applicableLooking for participantsNCT06954233
What this trial is testing

Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer

Who this might be right for
Testicular Cancer
Jagiellonian University 20
Not applicableStudy completedNCT05631379
What this trial is testing

Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma

Who this might be right for
Retroperitoneal SarcomaBody CompositionMalnutrition+3 more
Institute of Oncology Ljubljana 100
Large-scale testing (Phase 3)Looking for participantsNCT04031677
What this trial is testing

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Who this might be right for
Retroperitoneal SarcomaLiposarcomaLeiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC 250
Not applicableStudy completedNCT05377632
What this trial is testing

Comparing Two Different Approaches in Robotic-Assisted Renal Surgery

Who this might be right for
Renal Tumor
Lukas J Hefermehl 40
Testing effectiveness (Phase 2)Ended earlyNCT02207309
What this trial is testing

Pazopanib Maintenance Phase II

Who this might be right for
Sarcoma
Ludwig-Maximilians - University of Munich 1
Early research (Phase 1)Active Not RecruitingNCT03361436
What this trial is testing

Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

Who this might be right for
LiposarcomaMalignant Abdominal NeoplasmMalignant Retroperitoneal Neoplasm+3 more
OHSU Knight Cancer Institute 15
Not applicableUnknownNCT03480399
What this trial is testing

Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas

Who this might be right for
Sarcoma, Soft TissueRetroperitoneal NeoplasmsSurgery+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 60
Not applicableStudy completedNCT01360411
What this trial is testing

Tissue Characterisation by Endoscopic GI-elastography

Who this might be right for
Disorder of Upper Gastrointestinal TractPancreatic NoduleSecondary and Unspecified Malignant Neoplasm of Retroperitoneal Lymph Nodes+1 more
Haukeland University Hospital 137
Testing effectiveness (Phase 2)UnknownNCT02797626
What this trial is testing

Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

Who this might be right for
Stage II A/B Seminomatous Germ Cell Tumors
Heinrich-Heine University, Duesseldorf 30
Next Page